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Because urine ion excretion varies throughout the day,
clinicians monitor 24 h urine samples to measure ion excretion
and supersaturation in kidney stone patients. However, these
results are averages and may not reflect maximal
supersaturation which drives stone formation. We measured
ion excretion and saturation in genetic hypercalciuric stone-
forming rats on both a normal or low calcium diet over 0–3,
3–6 and 6–24 h using two feeding protocols, where the daily
food allotment was fed either as a bolus or divided into three
portions. With a normal calcium diet, urine calcium, oxalate,
volume, and calcium oxalate supersaturation were
significantly greater on the bolus compared to the divided
feeds in the prandial and postprandial periods. Bolus eaters
also excreted more calcium and oxalate and had increased
volume over 24 h. Maximal calcium oxalate supersaturation
was greater during the initial time periods than during the
entire 24 h, regardless of the feeding schedule. With the low
calcium diet, the effect of bolus feeding was reduced. Thus,
urine ion excretion and supersaturation vary with the type of
feeding. If these results are confirmed in man, it suggests that
eating as a bolus may result in greater prandial and
postprandial calcium oxalate supersaturation. This may
increase growth on Randall’s plaques and promote stone
disease.
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Hypercalciuria is the most common metabolic abnormality
found in humans with nephrolithiasis.1–5 Hypercalciuria
raises urine saturation with respect to the solid phases of
calcium hydrogen phosphate (CaHPO4, brushite) and
calcium oxalate (CaOx) enhancing the probability of
nucleation and growth of crystals into clinically significant
kidney stones.1,2,4
We have established a model of hypercalciuria and
nephrolithiasis by successively inbreeding 71 generations of
the most hypercalciuric progeny of the most hypercalciuric
Sprague–Dawley rats found on an initial screen. Each rat now
excretes 8–10 times as much urinary (U) calcium (Ca) as
similarly fed controls.6–28 The hypercalciuria is due to
increased intestinal Ca absorption6,7 coupled to a defect in
renal tubular Ca reabsorption7,15 and enhanced bone
resorption,11 suggesting a systemic dysregulation of Ca
homeostasis.8 Stone formation in both humans and rats
shares many metabolic features; stone formation in humans
also has increased intestinal Ca absorption, increased bone
resorption, and decreased renal tubule Ca reabsorption.1,3
Virtually, all of these hypercalciuric rats form kidney stones
while there is no evidence of stone formation in the control
rats.10 We have termed the rats genetic hypercalciuric stone-
forming (GHS) rats.10,12,14,16,18,20–22 The stones formed by
the GHS rats fed normal rat chow contain only Ca and
P.10,14,20,21 The dietary addition of hydroxyproline, a
common amino acid and an oxalate precursor,29 results in
formation of CaOx kidney stones.18,22
In our clinical treatment strategies for human nephro-
lithiasis, we assume that a 24 h U collection with calculation
of supersaturation (SS) is the best predictor of whether an
individual will form a stone and, if a stone is formed, of its
solid phase.1–3,5,30–33 However, recent human studies have
demonstrated CaOx stone formation in patients whose 24 h
U is normal with respect to this solid phase.34 The lack of
demonstrable increase in SS may be a function of the
averaging nature of a 24 h urine collection. Serum Ca
fluctuates throughout the day.35–38 If SS also varies through-
out the day, the maximal supersaturation and thus the
maximal driving force for crystallization will not be
measured.31 After eating, Ca is rapidly absorbed leading to
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small, but measurable, increases in serum levels.35,38 An
increased serum level, with no change in kidney function,
leads to an increase in the filtered load of Ca. An increased
filtered load results in increased UCa and, may increase the
SS, unless U volume (V) also increases after eating, for the
solid phases CaOx and CaHPO4. Urine Ca while eating, and
in the immediate postprandial period, exceeds UCa during
periods of fasting, such as prior to the morning meal;39
however, the potential benefit of multiple small feedings vs
large bolus feedings in reducing peak UCa and USS has never
been tested. The goal of this study is to test the hypothesis
that USS with respect to CaOx and CaHPO4 is maximal soon
after eating and is greater when the daily food allotment is
eaten as a bolus rather than in a divided fashion.
RESULTS
Urine calcium excretion
While being fed the normal Ca (1.2% Ca) diet, the bolus-fed
GHS rats excreted significantly more UCa at 0–3 h, 3–6 h, the
prandial and postprandial periods, respectively, and 0–24 h
when compared to the rats fed in a divided manner
(Figure 1). When being fed the low Ca diet (0.02% Ca),
the bolus-fed GHS rats excreted significantly more UCa at
3–6 h, 6–24 h, and 0–24 h when compared to the rats fed in a
divided manner.
Urine oxalate excretion
While being fed the normal Ca diet, the bolus-fed GHS rats
excreted significantly more UOx at 0–3 h, 3–6 h, and 0–24 h
when compared to the rats fed in a divided manner
(Figure 2). When being fed the low Ca diet, the bolus-fed
GHS rats excreted significantly more UOx at 0–3 h, but not
0–24 h, when compared to the rats fed in a divided manner.
Urine phosphorus excretion
While being fed the normal Ca diet, the bolus-fed GHS rats
excreted significantly more UP at 0–3 h and significantly less
UP at 6–24 h when compared to the rats fed in a divided
manner (Figure 3). When being fed the low Ca diet, the
bolus-fed GHS rats had no differences in UP when compared
to the rats fed in a divided manner during any time period.
Urine pH
While being fed the normal Ca diet, the bolus-fed GHS rats
had a significantly higher UpH at 3–6 h and a significantly
lower UpH at 6–24 h when compared to the rats fed in a
divided manner (Figure 4). When being fed the low Ca diet,
the bolus-fed GHS rats had no differences in UpH when
compared to the rats fed in a divided manner during any
time period.
Urine volume
While being fed the normal Ca diet, the bolus-fed GHS rats
excreted significantly more UV at 0–3 h, 3–6 h, 6–24 h, and
0–24 h when compared to the rats fed in a divided manner
(Figure 5). When being fed the low Ca diet, the bolus-fed
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Figure 1 | Urine calcium excretion during three different time
periods while genetic hypercalciuric stone-forming rats were fed
either a normal (1.2%) or low (0.02%) Ca diet. Twenty-four
seventy-first generation female GHS rats were divided into two
groups and placed in metabolic cages. Throughout days 1–14, each
rat in each group was fed 13 g per day of a normal Ca diet. One group
received their daily food allotment as a bolus at time 0 (Bolus), and
the other group received their allotment divided into three (Div)
portions at 0, 6, and 9 h. All bolus-fed rats completely consumed the
food within 15 min of food presentation. During the last 4 days of this
period (days 11–14), successive urine collections were obtained 0–3,
3–6, and 6–24 h. Throughout days 15–28, each rat in each group was
fed 13 g per day of a low Ca diet. Rats were fed in the same groups as
assigned in days 1–14. During the last 4 days of this period, successive
urine collections were obtained as during days 11–14. *Po0.05 vs
Bolus, same time period.
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Figure 2 | Urine oxalate excretion. Protocol and abbreviations as
in Figure 1.
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GHS rats excreted significantly more UV only at 6–24 h when
compared to the rats fed in a divided manner.
Urine CaOx supersaturation
While being fed the normal Ca diet, the bolus-fed GHS rats
had a higher CaOx SS at 0–3 h and 3–6 h when compared to
the rats fed in a divided manner (Figure 6). While being fed
the normal Ca diet, both the bolus-fed and the GHS rats fed
in a divided manner had greater SS with respect to CaOx at
both 0–3 h and 3–6 h compared to both 6–24 h and 0–24 h and
with the rats fed in a divided manner, the SS at 3–6 h was
greater than at 0–3 h.
While being fed the low Ca diet, the bolus-fed GHS
rats had a higher CaOx SS at 3–6 h when compared to the rats
fed in a divided manner. While being fed the low Ca diet,
there were no differences with respect to CaOx in the bolus-
fed GHS rats at any time period. While being fed the low Ca
diet, the GHS rats fed in a divided manner had greater SS
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Figure 3 | Urine phosphorus excretion. Protocol and abbreviations
as in Figure 1.
1.2% Ca diet
0.02% Ca diet
Bolus
0–3 h 3–6 h 6–24 h 0–24 h
Div Bolus Div Bolus Div Bolus Div
Ur
in
e 
pH
8
6
4
2
0
6
4
2
0
8
∗
∗
Figure 4 | Urine pH. Protocol and abbreviations as in Figure 1.
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Figure 5 | Urine volume. Protocol and abbreviations as in Figure 1.
1.2% Ca diet
0.02% Ca diet
Bolus
0–3 h 3–6 h 6–24 h 0–24 h
Div Bolus Div Bolus Div Bolus Div
Ca
O
x 
Su
pe
rs
at
ur
at
io
n
25
20
15
10
5
0
6
4
2
0
∗
∗
∗
#
#
# #
#
#
Figure 6 | Urine supersaturation with respect to the calcium
oxalate (CaOx) solid phase. Protocol and abbreviations as in
Figure 1. *Po0.05 vs Bolus, same time period; 1Po0.05 vs 0–3 h time
period, same group; #Po0.05 vs 3–6 h time period same group.
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with respect to CaOx at both 6–24 h and 0–24 h compared
to 3–6 h.
Urine CaHPO4 supersaturation
While being fed the normal Ca diet, the bolus-fed GHS rats
had a significantly lower CaHPO4 SS at 3–6 h, 6–24 h, and
0–24 h when compared to the rats fed in a divided manner
(Figure 7). While being fed the normal Ca diet, both the
bolus-fed and GHS rats fed in a divided manner had greater
SS with respect to CaHPO4 at both 0–3 h and 3–6 h compared
to both 6–24 h and 0–24 h, and in the rats fed in a divided
manner, the SS at 3–6 h was greater than at 0–3 h.
While being fed the low Ca diet, the bolus-fed GHS rats
did not have any differences in CaHPO4 SS at any time
period when compared to the rats fed in a divided manner.
While being fed the low Ca diet, both the bolus-fed and the
GHS rats fed in a divided manner had greater SS with respect
to CaHPO4 at 3–6 h and a lower SS at 6–24 h compared to
0–3 h.
DISCUSSION
The GHS rats were bred for hypercalciuria, the most
common metabolic abnormality in patients with nephro-
lithiasis. Studies of the pathophysiology of the hypercalciuria
in the GHS rats reveal that, similar to many patients with
idiopathic hypercalciuria, they have increased intestinal Ca
absorption,6,7 reduced renal Ca reabsorption,7,15 and ex-
cessive bone resorption.11 The dysregulation of Ca transport
at these sites suggests a systemic abnormality in Ca home-
ostasis.8 Indeed, we have shown that there is an increase in
the number of vitamin D receptors in intestine, bone, and
kidney8,11,17,25 and calcium receptors in kidney23 of the GHS
compared to non-hypercalciuric Sprague–Dawley rats, the
parental strain of the GHS rats. When eating a normal Ca
diet, virtually all of the GHS rats form kidney stones
composed solely of CaHPO4.
10,14,20,21 The addition of
hydroxyproline, an oxalate precursor, to the diet induces
the GHS rats to form CaOx stones.18,22 As the diet and
environment of these rats can be rigorously controlled, they
are an ideal animal model to test hypotheses that are difficult
to test in man. In this study, we used the GHS rats to test the
hypotheses that urine supersaturation with respect to CaOx
and CaHPO4 is maximal soon after eating and is greater
when the daily food allotment is eaten as a bolus rather than
in a divided fashion.
On an ample Ca diet, UCa excretion was greater in the
prandial (0–3 h) and postprandial (3–6 h) periods, when the
GHS rats were offered their daily food allotment as a bolus
compared to when the rats were given the first of three equal
portions of a food at time 0. Total 24-h UCa excretion was
greater in the GHS rats fed as a bolus compared to when the
rats received a similar amount of food given in divided doses.
That more Ca is absorbed in this ample Ca diet in the
prandial and postprandial period is not surprising, as a
portion of the increased amount of dietary Ca would be
absorbed resulting in a greater filtered load of Ca and greater
UCa excretion. However, what is surprising is that the bolus-
fed rats actually had greater UCa excretion over the entire 24-
h period than the rats fed in the three divided portions. It is
unclear why the Ca in a bolus of food should result in a
greater UCa than when the same amount of food is given in a
divided fashion. Perhaps, there is increased intestinal
absorption when the luminal Ca concentration is very high
after a large bolus, increasing unregulated paracellular
absorption. Active intestinal transport of calcium via the
transcellular route occurs predominantly in the duodenum
and the upper jejunum, under the control of calcitriol.
However, in the lower jejunum and ileum, calcium absorp-
tion is primarily paracellular and dependent on the
concentration of calcium in the intestinal lumen.40
While there was a marked decrease in available Ca for
absorption when GHS rats were fed a low Ca diet, there was
still greater UCa excretion in the 3–6 h and 6–24 h period and
over the entire 24 h in the bolus-fed rats compared to the rats
fed in a divided manner. Thus, even when dietary calcium is
quite limited, more of it is apparently absorbed and excreted
in the bolus-fed rats. As we did not measure intestinal Ca
absorption, it is not clear if the additional UCa was derived
from the diet or perhaps from the bone. We have previously
shown that GHS rats are often in negative Ca balance, that is,
UCa excretion exceeds intestinal Ca absorption when fed this
low Ca diet.7 Perhaps, the single-bolus feeding leads to higher
rates of bone resorption during the prolonged fast between
feedings.
On the normal Ca diet, UOx excretion mirrored UCa
excretion: that is, more Ox was excreted in the bolus-fed rats
in the prandial, postprandial, and over the entire 24-h time
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Figure 7 | Urine supersaturation with respect to the calcium
hydrogen phosphate (CaHPO4, brushite) solid phase. Protocol
and abbreviations as in Figure 1. *Po0.05 vs Bolus, same time period;
1Po0.05 vs 0–3 h time period, same group; #Po0.05 vs 3–6 h time
period, same group.
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period. In humans, UOx has been shown to be dependent on
dietary Ca; the greater dietary Ca, the less Ox is excreted
presumably due to more intestinal CaOx binding making the
Ox less available for absorption.41 Perhaps, if the bolus-fed rats
absorbed more Ca, there was more available Ox for absorption
and subsequent excretion. Changes in UP were more modest
between the bolus and rats fed in a divided manner. Only in
the prandial period was UP greater in the bolus-fed rats, and
UP was actually greater in the animals fed in a divided manner
in the 6- to 24-h time period resulting in no difference in UP
excretion between the two types of feeding over the entire 24-h
time period. As expected, compared to the normal Ca diet, the
low Ca diet resulted in far more UP excretion at all time
periods (Figure 3). As we have shown previously, this is due to
more P availability in diets low in Ca.20
Formal measurements of intestinal ion absorption and
markers of bone accretion and resorption will be necessary to
completely understand the differences in UCa, UOx, and UP
excretion in the bolus compared to the rats fed in a divided
manner during each of these time periods.
On the normal Ca diet, UV was higher in the rats fed food as
a bolus compared to those fed in a divided manner. We have
previously reported that when fed the same diet, the GHS rats
are polyuric compared to control rats.15 The higher UV in the
prandial and postprandial periods could be due to the higher
solute load in the bolus-fed rats or possibly due to activation of
the luminal collecting duct Ca receptor, which is thought to
effect vasopressin-induced water reabsorption.42 The higher UV
during the 6- to 24-h time period could be due to a higher
luminal ionized Ca, as there is less UP to complex the UCa.
Recently, Worcester et al.39 published on the changes in
renal handling of Ca with feeding in normal subjects and
patients with idiopathic hypercalciuria. They found that
compared to the fasting state, urine Ca increased after meals,
as we have shown in the GHS rats, due to a fall in the
fractional reabsorption of Ca and fell further in the
idiopathic stone formers than in the normal controls. Neither
UOx nor SS was reported, so the effect on USS could not be
compared to the data we present here in the GHS rat model.
Evan et al.34 have demonstrated that a CaP solid phase is
the first crystal detected in humans with CaOx kidney stones.
This solid phase is initially found surrounding the thin loops
of Henle and then expands and erodes into the urinary space
where it provides a nidus for heterogenous nucleation of
CaOx with subsequent clinically significant stone formation.
It is unclear what drives the initial CaP formation, the so-
called Randall’s plaque, but the plaque formation is
correlated with UV, UCa, and UpH. The bolus-fed animals
had a higher UCa, which would favor CaP plaque formation
but also a higher UV, which would not favor plaque
formation. There is not enough data in humans to study
the interaction of V and Ca to determine which would have
an overriding effect on the formation of plaque in man.
Reducing urine supersaturation with respect to CaOx
could reasonably be thought to reduce clinical stone
formation as the lower the urine CaOx supersaturation, the
lower the chance for heterogenous nucleation and growth on
Randall’s plaque. On the normal Ca diet, the CaOx super-
saturation was greater in the prandial and postprandial
period and also greater when the entire allotment of food was
given as a bolus. If peak supersaturation drives stone
formation, then it would suggest that there would be less
stone formation in GHS rats fed in a divided manner. While
this study was not designed to determine stone formation, we
have previously shown that kidney stone formation in the
GHS rats is critically dependent on USS over the 24-h period
and that reductions in this SS are associated with reduced
stone formation in the GHS rats.20
If this study performed in GHS rats can be confirmed in
humans, it would suggest that humans eating a similar diet in
divided meals would have less urinary CaOx SS, resulting in
less stone formation, than those eating a similar amount of
food in one sitting.
MATERIALS AND METHODS
Establishment of hypercalciuric rats
Adult Sprague–Dawley rats (Charles River Laboratories, Kingston,
NY, USA) were initially screened for hypercalciuria by placing the
rats in individual metabolic cages, feeding them a constant amount
of a normal Ca diet, and measuring UCa. The most hypercalciuric
male and female rats were used to breed the next generation. A
similar protocol was used for screening and inbreeding of
subsequent generations.6–28
Twenty-four seventy-first generation female GHS rats, initially
weighing on average 192 g, were divided into two groups and placed
in metabolic cages and given free access to deionized distilled water
throughout the study. Throughout days 1–14, each rat in each group
was fed 13 g per day of a normal Ca diet (1.2% Ca and 0.65% P;
Harlan Teklad, Madison, WI, USA). One group received their daily
food allotment as a bolus at time 0 (Bolus), and the other group
received their allotment divided into three divided (Div) portions at
0, 6, and 9 h. The bolus-fed rats all completely consume the offered
food within 15 min of presentation. During the last 4 days of this
period (days 11–14), 4 days of successive U collections were obtained
0–3, 3–6, and 6–24 h. Rats invariably urinate when the person
collecting the urine walks into the room, ensuring a complete
collection over the time periods reported.
Throughout days 15–28, each rat in each group was fed 13 g per
day of a matched low Ca diet (0.02% Ca and 0.65% P, Harlan
Teklad). Both the normal Ca diet and the low Ca diet contained
0.24% magnesium, 0.40% sodium, 0.43% potassium, and 2.2 IU
vitamin D3 per gram of food.
6,8,15 Rats were fed in the same groups
as assigned in days 1–14. During the last 4 days of this period,
successive urine collections were obtained as during days 11–14.
During both time periods, 2 days of U were collected in
concentrated HCl for all measurements except for pH, uric acid, and
chloride, and 2 days of U were collected in the presence of thymol
for measurement of pH, uric acid, and chloride. All samples were
refrigerated at 41C until measurement, and all measurements were
completed within 2 weeks.
Urine chemical determinations
Calcium was measured by reaction with arsenazo III and then
determined photometrically at 650 nm.43 Creatinine was determined
by a modification of the Jaffe method by formation of a
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creatinine–picrate complex.44 Inorganic P was measured by reaction
with ammonium molybdate to form a colored phosphomolybdate
complex.45 Uric acid was measured after oxidation by uricase to
produce allantoin and hydrogen peroxide.46 Magnesium was
determined by combination with calmagite.47 Ammonia was
determined by coupled enzyme system using glutamate dehydro-
genase and nicotinamide adenine dinucleotide phosphate.48 Sodium
was determined by a selective electrode,49 and potassium using a
valinomycin membrane attached to a potassium electrode.50
Chloride was measured using a silver/silver chloride electrode.51
Oxalate, citrate, and sulfate were measured by ion chromatography
using a Dionex ICS 2000 system (Dionex Corporation, Sunnyvale,
CA, USA) equipped with an AG-11 guard column and AS-11
analytical column in series. The mobile phase was potassium
hydroxide at a flow rate of 2 ml min1. Ion peaks were detected
using a conductivity meter with the eluant background conductivity
suppressed using an anion self-regenerating suppressor (ASRS Ultra
II; Dionex Corp.). Ultrafiltrates of urine were prepared using a
10 kDa cutoff membrane and then diluted 1:20 in 0.3 M boric acid
and loaded onto the column using a 25-ml sample loop.52
Urine supersaturation
The CaOx and the CaHPO4 ion activity products were calculated
using the computer program EQUIL.53–55 The computer program
calculates free ion concentrations using the concentrations of
measured ligands and known stability constants. Ion activity
coefficients are calculated from ionic strength using the Davies
modification of the Debye–Huckel solution to the Poisson–Boltz-
mann equation. The program simultaneously solves for all known
binding interactions among the measured substances. Oxalate, P,
and Ca ion activities were used to calculate the free-ion activity
products. The free ions in solution are considered to be in an
equilibrium with the dissolved CaOx governed by a stability
constant (K) of 2.746 103 M1 and with the dissolved CaHPO4
governed by a K of 0.685 103 M1. The value of CaOx in a solution
at equilibrium with a solid phase of CaOx, the solubility of CaOx, is
6.16 106 M per liter. The value of CaHPO4 in a solution at
equilibrium with a solid phase of CaHPO4, the solubility of brushite,
is 3.981 107 M l1. The relative supersaturation for CaOx is
calculated as the ratio of the free-ion activity product of Ca and Ox
in the individual urine to the solubility of CaOx. The relative
supersaturation for CaHPO4 is calculated as the ratio of the free-ion
activity product of Ca and P in the individual urine to the solubility
of CaHPO4. Ratios of 1 connote a sample at equilibrium, above 1
supersaturation, and below 1 undersaturation. We have used this
computer program previously and found excellent correspondence
between calculated and experimentally measured saturation in urine
and blood,7,9,10,12,14,16,18,20–22,24,26 and in bone culture medium.56–58
Statistical analyses
All values are expressed as mean±s.e.m. Tests of significance were
calculated by t-tests and analysis of variance, as appropriate, using
conventional computer programs (BMDP; University of California,
Los Angeles, CA, USA). Bonferroni corrections were utilized for
multiple comparisons. Po0.05 was considered significant.
DISCLOSURE
David A Bushinsky, Anne C Michalenka, and Kelly LaPlante Strutz have no
conflict of interest to disclose. Susan Donahue and John R Asplin are both
employees of Lab Corp., which is a company that measures urine
chemistries.
ACKNOWLEDGMENTS
This work was supported in part by Grants 1 R43 DK075194 and
1 RO1 AR46289 from the National Institutes of Health.
REFERENCES
1. Monk RD, Bushinsky DA. Kidney stones. In: Larsen PR, Kronenberg HM,
Melmed S, Polonsky KS (eds). Williams Textbook of Endocrinology, 10th
edn, W.B. Saunders: Philadelphia, 2003, pp 1411–1425.
2. Monk RD, Bushinsky DA. Nephrolithiasis and nephrocalcinosis. In:
Johnson R, Frehally J (eds). Comprehensive Clinical Nephrology, 2nd edn,
Mosby: London, 2003, pp 731–744.
3. Bushinsky DA. Nephrolithiasis. J Am Soc Nephrol 1998; 9: 917–924.
4. Coe FL, Favus MJ, Asplin JR. Nephrolithiasis. In: Brenner BM (ed). The
Kidney, 7th edn, W.B. Saunders Company: Philadelphia, 2004, pp
1819–1866.
5. Bushinsky DA. Renal lithiasis. In: Humes HD (ed). Kelly’s Textbook of
Medicine. Lippincott Williams & Wilkens: New York, 2000, pp 1243–1248.
6. Bushinsky DA, Favus MJ. Mechanism of hypercalciuria in genetic
hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin
Invest 1988; 82: 1585–1591.
7. Kim M, Sessler NE, Tembe V et al. Response of genetic hypercalciuric rats
to a low calcium diet. Kidney Int 1993; 43: 189–196.
8. Li X-Q, Tembe V, Horwitz GM et al. Increased intestinal vitamin D receptor
in genetic hypercalciuric rats: a cause of intestinal calcium
hyperabsorption. J Clin Invest 1993; 91: 661–667.
9. Bushinsky DA, Kim M, Sessler NE et al. Increased urinary saturation and
kidney calcium content in genetic hypercalciuric rats. Kidney Int 1994; 45:
58–65.
10. Bushinsky DA, Grynpas MD, Nilsson EL et al. Stone formation in genetic
hypercalciuric rats. Kidney Int 1995; 48: 1705–1713.
11. Krieger NS, Stathopoulos VM, Bushinsky DA. Increased sensitivity to
1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am J Physiol (Cell
Physiol) 1996; 271: C130–C135.
12. Bushinsky DA, Bashir MA, Riordon DR et al. Increased dietary oxalate does
not increase urinary calcium oxalate saturation in hypercalciuric rats.
Kidney Int 1999; 55: 602–612.
13. Bushinsky DA. Genetic hypercalciuric stone forming rats. Semin Nephrol
1996; 16: 448–457.
14. Asplin JR, Bushinsky DA, Singharetnam W et al. Relationship between
supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int
1997; 51: 640–645.
15. Tsuruoka S, Bushinsky DA, Schwartz GJ. Defective renal calcium
reabsorption in genetic hypercalciuric rats. Kidney Int 1997; 51:
1540–1547.
16. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS. Alendronate decreases
urine calcium and supersaturation in genetic hypercalciuric rats. Kidney
Int 1999; 55: 234–243.
17. Yao J, Kathpalia P, Bushinsky DA, Favus MJ. Hyperresponsiveness of
vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3: A new
characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest
1998; 101: 2223–2232.
18. Evan AP, Bledsoe SB, Smith SB, Bushinsky DA. Calcium oxalate crystal
localization and osteopontin immunostaining in genetic hypercalciuric
stone-forming rats. Kidney Int 2004; 65: 154–161.
19. Bushinsky DA. Genetic hypercalciuric stone-forming rats. Curr Opin
Nephrol Hypertens 1999; 8: 479–488.
20. Bushinsky DA, Parker WR, Asplin JR. Calcium phosphate supersaturation
regulates stone formation in genetic hypercalciuric stone-forming rats.
Kidney Int 2000; 57: 550–560.
21. Bushinsky DA, Grynpas MD, Asplin JR. Effect of acidosis on urine
supersaturation and stone formation in genetic hypercalciuric stone
forming rats. Kidney Int 2001; 59: 1415–1423.
22. Bushinsky DA, Asplin JR, Grynpas MD et al. Calcium oxalate stone
formation in genetic hypercalciuric stone-forming rats. Kidney Int 2002;
61: 975–987.
23. Yao J, Karnauskas AJ, Bushinsky DA, Favus MJ. Regulation of renal calcium
receptor gene expression in response to 1,25(OH)2D3 in genetic
hypercalciuric stone-forming rats. J Am Soc Nephrol 2005; 16:
1300–1308.
24. Bushinsky DA, Asplin JR. Thiazides reduce brushite, but not calcium
oxalate, supersaturation and stone formation in genetic hypercalciuric
stone-forming rats. J Am Soc Nephrol 2005; 16: 417–424.
25. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ et al. Mechanism and
function of high vitamin D receptor levels in genetic hypercalciuric stone-
forming rats. J Bone Miner Res 2005; 20: 447–454.
428 Kidney International (2008) 73, 423–429
o r i g i n a l a r t i c l e DA Bushinsky et al.: Bolus vs divided feeding on urine supersaturation
26. Bushinsky DA, LaPlante K, Asplin JR. Effect of cinacalcet on urine calcium
excretion and supersaturation in genetic hypercalciuric stone-forming
rats. Kidney Int 2006; 69: 1586–1592.
27. Bushinsky DA, Frick KK, Nehrke K. Genetic hypercalciuric stone-forming
rats. Curr Opin Nephrol Hypertens 2006; 15: 403–418.
28. Hoopes Jr RR, Middleton FA, Sen S et al. Isolation and confirmation of a
calcium excretion quantitative trait locus on chromosome 1 in genetic
hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 2006; 17:
1292–1304.
29. Hagler L, Herman RH. Oxalate metabolism. I. Am J Clin Nutr 1973; 26:
758–765.
30. Bushinsky DA. Recurrent hypercalciuric nephrolithiasis—does diet help?
N Engl J Med 2002; 346: 124–125.
31. Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest
2003; 111: 602–605.
32. Monk RD, Bushinsky DA. Pathogenesis of idiopathic hypercalciuria. In:
Coe F, Favus M, Pak C, Parks J, Preminger G (eds). Kidney Stones: Medical
and Surgical Management. Lippincott-Raven: Philadelphia, 1996, pp
759–772.
33. Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. Am J Physiol
(Renal Fluid Electrolyte Physiol) 1984; 247: F1–F13.
34. Evan AP, Lingeman JE, Coe FL et al. Randall’s plaque of patients with
nephrolithiasis begins in basement membranes of thin loops of Henle.
J Clin Invest 2003; 111: 607–616.
35. Bushinsky DA. Calcium, magnesium, and phosphorus: renal handling and
urinary excretion. In: Favus MJ (ed). Primer on the Metabolic Bone Diseases
and Disorders of Mineral Metabolism, 5th edn, American Society for Bone
and Mineral Research: Washington, DC, 2003, pp 97–105.
36. Monk RD, Bushinsky DA. Treatment of calcium, phosphorus, and
magnesium disorders. In: Halperin M (ed). Therapy in Nephrology and
Hypertension: A Companion to Brenner and Rector’s The Kidney. W.B.
Saunders Company: Philadelphia, 1999, pp 303–315.
37. Bushinsky DA, Monk RD. Electrolyte quintet: Calcium. Lancet 1998; 352:
306–311.
38. Bushinsky DA. Disorders of calcium and phosphorus homeostasis. In:
Greenberg A (ed). Primer on Kidney Diseases, 4th edn, Academic Press: San
Diego, 2005, pp 120–130.
39. Worcester EM, Gillen DL, Evan AP et al. Evidence that postprandial
reduction of renal calcium reabsorption mediates hypercalciuria of
patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 2007;
292: F66–F75.
40. Bronner F. Mechanisms of intestinal calcium absorption. J Cell Biochem
2003; 88: 387–393.
41. Lemann Jr J, Pleuss JA, Worcester EA et al. Urinary oxalate excretion
increases with body size and decreases with increasing dietary calcium
intake among healthy adults. [published erratum appears in Kidney Int
1996; 50: 341]. Kidney Int 1996; 49: 200–208.
42. Procino G, Carmosino M, Tamma G et al. Extracellular calcium
antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct
cells. Kidney Int 2004; 66: 2245–2255.
43. Michalylova V, Ilkova P. Photometric determination of microamounts of
calcium with arsenazo III. Anal Chim Acta 1971; 53: 194–198.
44. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct
colorimetric method. Clin Chim Acta 1973; 43: 305–310.
45. Ichida T, Hine N. Improvement of Baginski’s method for phosphorus
determination. Clin Chim Acta 1969; 23: 378–379.
46. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2-
hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in
direct enzymic assay of uric acid in serum and urine. Clin Chem 1980; 26:
227–231.
47. Abernathy MH, Fowler RT. Micellar improvement of the calmagite
compleximetric measurement of magnesium in plasma. Clin Chem 1982;
28: 520–522.
48. Ratliff CR, Hall FF. Ammonia in plasma enzymatic procedure. Selected
Methods Clin Chem 1982; 9: 85–90.
49. Eisenman G, Rudin DO, Casby JU. Glass electrode for measuring sodium
ion. Science 1957; 126: 831–834.
50. Stefanac Z, Simon W. Highly selective cation electrode systems based on
in-vitro behavior of macrotetrolides in membranes. Chimica 1966; 20:
436–440.
51. Cotlove E. Chloride. In: Seligson D (ed). Standard Methods in Clinical
Chemistry. Academic Press: New York, 1961, pp 81–92.
52. Jiang Z, Asplin JR, Evan AP et al. Calcium oxalate urolithiasis in mice
lacking anion transporter Slc26a6. Nat Genet 2006; 38: 474–478.
53. Finlayson B. Calcium stones: some physical and clinical aspects. In: David
DS (ed). Calcium Metabolism in Renal Failure and Nephrolithiasis. Wiley:
New York, 1977, pp 337–382.
54. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2: a BASIC computer
program for the calculation of urinary saturation. J Urol 1985; 134:
1242–1244.
55. Brown CM, Ackermann DK, Purich DL. EQUIL93: a tool for experimental
and clinical urolithiasis. Urol Res 1994; 22: 119–126.
56. Bushinsky DA, Chabala JM, Levi-Setti R. Comparison of in vitro and in vivo
44Ca labeling of bone by scanning ion microprobe. Am J Physiol (Endoc
rinol Metab 22) 1990; 259: E586–E592.
57. Bushinsky DA, Lechleider RJ. Mechanism of proton-induced bone calcium
release: calcium carbonate-dissolution. Am J Physiol (Renal Fluid
Electrolyte Physiol 22) 1987; 253: F998–F1005.
58. Bushinsky DA, Gavrilov K, Chabala JM et al. Effect of metabolic acidosis on
the potassium content of bone. J Bone Miner Res 1997; 12: 1664–1671.
Kidney International (2008) 73, 423–429 429
DA Bushinsky et al.: Bolus vs divided feeding on urine supersaturation o r i g i n a l a r t i c l e
